Clinical Trial Update: The Ischemia Modified Albumin In Diagnosing Ischemic New Events

View source ↗

Summary

A clinical trial evaluating ischemia-modified albumin for diagnosing new ischemic events was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ischemic Heart Disease
• Myocardial Ischemia
• Unstable Angina

Snippet

Sponsor: Inverness Medical Innovations | Conditions: Heart Disease, Ischemic, Ischemia, Myocardial | Status: TERMINATED